Ir al contenido principal de la página
Logotipo Talemnology

Talemnology is a startup focused on technology transfer in the Healthcare sector

Currently we focus on the diagnosis of NASH and fibrosis and monitoring of patients with CHF.

DeMILI is a project supported by the European Commission through the SMEs Instrument under the framework program H2020.

To learn more, go to our web www.talemnology.com

We maintain partnerships with research groups, both clinical and bioengineering with which co-develop our projects.
 
DeMILI is a development of the teams led by Professors Manuel Romero Gomez and Emilio Gómez belonging to IBIS (Institute of Bioengineering of Seville) and the University of Seville. Minimally Invasive Surgery Center Jesús Usón is key partner in this project.

Manuel Romero-Gómez
  • UCM Digestive Diseases and CIBEREHD, Virgen Macarena-Virgen del Rocío University Hospitals, University of Sevilla, Sevilla, 41013, Spain
  • Instituto de Biomedicina de Sevilla (IBiS), University of Sevilla, Sevilla, 41013, Spain
Javier Ampuero
  • UCM Digestive Diseases and CIBEREHD, Virgen Macarena-Virgen del Rocío University Hospitals, University of Sevilla, Sevilla, 41013, Spain
  • Instituto de Biomedicina de Sevilla (IBiS), University of Sevilla, Sevilla, 41013, Spain

Emilio Gomez-Gonzalez: Group of Interdisciplinary Physics, Engineering School, University of Sevilla, Sevilla, Spain